PERSON DIRECTORY
Brandon
Brandon appears in 4 indexed conversations across Latent Space. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
Synthesis Superintelligence: from Semiconductors to Superconductors — Periodic Labs’ Liam Fedus and Ekin Dogus Cubuk
swyxBrandonLiam FedusEkin Dogus Cubuk
Periodic’s differentiated asset is timestamped lineage across failed experiments, computations, instrument data, code, discussions, and successes, enabling models to learn scientific process rather than published endpoints.Its AI-simulation-experiment loop targets automated characterization, with secure on-site semiconductor deployment as the near-term wedge, while the longer-term “matter compiler” faces unknown physical variables and difficulty discovering superconductors without a complete theory.
AI Scientists Are Here: Autonomous Labs & Synthesis Superintelligence — Periodic Labs
swyxBrandonLiam FedusEkin Dogus Cubuk
Periodic Labs is building AI, simulations, and high-throughput physical labs as a closed loop, with timestamped failures, instrument data, and campaign lineage potentially differentiating its scientific intelligence.Automated characterization—not humanoid robotics—is the near-term bottleneck, while secure on-site deployments for semiconductor companies could evolve from Copilot-style assistance toward outcome pricing; whether throughput can compress discovery without better physical representations remains the key risk.
🔬Searching the Space of All Possible Materials — Prof. Max Welling, CuspAI
AI is turning materials discovery into a search problem spanning semiconductors, energy, drugs, and carbon capture, as conventional scaling makes matter an upstream constraint.CuspAI has raised $130 million in about 20 months, but its moat depends on hard-to-build data, experiments, and human-guided workflows; lighthouse validation and new verticals remain key watchpoints.
🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery
Gabriele CorsoJeremy WohlwendBrandon
Boltz turns AlphaFold 3’s closed release into an open-source opportunity, combining generative structure-and-sequence design with affinity prediction, search, and workflows built for working scientists rather than GitHub users alone.Broad wet-lab testing found nanomolar binders on two-thirds of nine unseen targets, but the platform still produces candidates—not drugs—leaving ADME, toxicity, cellular context, and iterative validation as the commercialization bottlenecks.